Duke Investments

Duke has invested in 5 companies and its latest investment was Sidecar Health on Jun 25, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Sidecar Health is a California-based insurtech platform that provides health insurance coverage for individuals, employees and employers.
$165M
Jun 25, 2024
-
Ozette is a Seattle-based health-tech firm that provides solutions such as AI-driven cell discovery and immune monitoring for the life sciences industry.
$26M
Jul 27, 2022
-
EternaTear is a pharmaceutical company that researches and develops non-prescription eyedrop for the treatment of dry eye syndrome.
$4.9M
Oct 06, 2020
-
clypd is an audience-based sales platform that offers workflow automation and data-enhanced decisioning for television and advertising businesses.
$19.4M
Apr 08, 2015
Oct 01, 2019
Orexigen Therapeutics is engaged in the development and commercialization of pharmaceutical products for the treatment of obesity​.
$35M
Mar 31, 2005
-

Frequently Asked Questions about Duke

  1. What is Duke investing in?

    Duke has invested in 5 companies including Sidecar Health, Ozette and EternaTear
  2. What company did Duke invest in?

    Duke invested in a total 5 companies including Sidecar Health, Ozette and EternaTear
  1. What are the top 5 investments by Duke?

    The top companies in which Duke invested are Sidecar Health, Ozette, EternaTear, Clypd and Orexigen Therapeutics, Inc.